However, since all three cytokines play an important role in host defense against infection as well as in the pathogenesis of autoimmune and inflammatory diseases (4, 12, 117, 120), a therapy that concomitantly targets the release of IL-1α, IL-1β and IL-18 is of high clinical interest. This evidence concerns the gene IL1B and infection.